W1: Neuromuscular pathologies Flashcards

1
Q

Describe the structure of skeletal muscle

A

A sarcomere consists of myofilaments (actin and myosin).
These are arranged together in a myofibril.
Myofibrils are grouped together into a muscle fibre (muscle cell), withintin the cell there will be multiple peripheral nuclei, sarcolemma and a sarcooplasm.
Each muscle fibre is surrounded by endomysium.
Group together to form muscle fascicles which are surrounded by periymysium
Group together the form muscle surrounded by epimysium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the process of action potential generation at a neuromuscular junction?

A

Action potential at nerve terminal causes release of ACh from nerve terminal
Binds to nicotinic receptors on the motor end plate, these are ligand gated Na+ channels that allow the influx of Na+ causing depolarisation of the membrane, when depolarisation is above threshold voltage-gated Na+ channels also open furthering depolarisation so action potential can be reached.
Depolarisation spread along the sarcolemma and transverse tubules.
T tubules contain dihydropyridine receptors (voltage-gated Ca2+ channels), the activation of these receptors causes a conformational change in themselves and ryanodine receptors in the close proximity sarcoplasmic reticulum, this allows Ca2+ to be released from the SR into the sarcoplasm and cause muscle contraction.
Hence Ca2+ provides the link in excitation-contraction coupling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a motor unit?

A

All the muscle fibres innervated by the same motor neuron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a motor end plate?

A

Also referred to as a neuromuscular junction
Is a site of specialised chemical synpase between the terminal branches of an axon and a muscle fibre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What protein is involed in limb girldel muscular dystrophy?

A

The sarcoglycan complex in the sarcolemma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the clinical presentations of DMD?

A

Positive Gowers sign
Hypertrophy of the calf
Loss of motor development (regression or failure)
Loss of or late milestones
Waddling gait
Characterised by Proximal muscle weakness
Heel cord shortening
Blunted intellect
TYpically tend to be a male patient aged 3-6yrs
Progressive condition often wheelchari bound to adolescence and cardiac arrhythmias and respiratory problems in later stages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the difference between Becker and Duchenne’s muscular dystrophy on a pathogenesis level?

A

Both are mutations in the same gene - dystrophen protein
Beckers - in frame mutation, typically mis-sense mutation. Some function of dystrophen protein remains, as the crucial ABD and CR,CT domains remain
Duchennes - out of frame mutation tends to be frameshift or non-sense mutation. Loss of function of protein. As the cystene binding domain tends to be absent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the differences in the clinical presentations of Duchennes and Beckers Muscular Dystrophy?

A

Beckers - diagnosed from age 5 upwards, typically up to 15 years old but can be after this. life expectancy of 40-50yrs, often able to walk until teens and early adult life, often from cardiac effects before skeletal problems

Duchennes - diagnosed between 3-6 years, life expectancy around 20-30yrs, wheelchair-bound by early teenage years, muscular skeletal symptoms are obvious from early on.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the role of dystrophin protein.

A

In skeletal muscle is part of a large complex of sarcolemma associated proteins that provides stability to the sarcolemma.
Protein consist of an N-terminal actin binding domain (ABD1) a central rod domain containing 4 hinge regions and 24 spectrin-like repeats, cystein rich domain for binding a beta dystroglycan and a C-terminus domain.
These carboxyl-terminal domains are important for anchoring to the sarcolemma via the dystrophin-glycoprotein complex, which then links to the endomysium by laminin.
This maintains the structural integrity os muscle fibre.

Has total of 79 exons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the consequences of a malfunctional dystrophin protein that is seen in DMD.

A

Non functional protein leads to inability to anchor actin to sarcolemma then endomysium
Therefore intracellular contractile forces are not spread from the sarcolemma to the ECM
Can lead to small membrane tears and calcium ion influx, accumulates in nucleus (alter gene expression) and the mitochondria (holes in membrane release of cytochrome C triggering apoptosis pathway) that cause myofibre degeneration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the morphological changes shown in muscle fibres in both DMD and BMD?

A

Variation in myofibre diameter
Increased numbers of internalized nuclei
Degeneration necrosis and phagocytosis of muscle fibres
Proliferative of endomysial connective tissue
late stage - muscle replaced by adipose tissue and water

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the common presentation of limb-girdle muscular dystrophy?

A

Common onset in later childhood or early adulthood
Muscle weakness in hips and things - struggle standing up, back pain, difficulty climbing stairs
Muscle weakness in arms - struggle lifting heavy objects, struggle to lift arms above the head.
Loss of muscle mass in affected areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the pathogenesis of limb-girdle muscular dystrophy?

A

Autosomal recessive condition fot type 2 or autosomal dominant for type 1.
Specific to LGMD 2F involves mutations in the δ-sarcoglycan gene, role in anchoring actin filaments to the sarcolemma
Weakness in the pelvic or shoulder girdle
Variable progression
Muscle fibre destruction and regeneration (milder than DMD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Where is the dystrophin gene expressed?
How?

A

Dystrophin is expressed predominantly in smooth, skeletal and cardiac muscle as well as some brain neurons.

Has eight different promoters hence allows different functional proteins to be made from the same gene. These different proteins are all dystrophin isoforms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is meant by a hinge region in DNA?*

A

Region that in a functional protein will link to other functional units together

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is a spectrin repeat region in DNA?*

A

Codes for a a specifc protein shape - three alpha helical coiled coils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What promotor acts on the dystrophin gene to form the dystrophin gene relevant in skeletal muscle in DMD?

A

Dp427m.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are some treatments currently being invested to treat DMD?

A

1) gene therapy - delivering a functional dystropgen gene using a viral vector
2) using an anti-sense oligonucleotide to skip the mutated exon so is excluded from final expressed mRNA in splicing (hence does not influence protein structure) - note still some change from normal gene typically changes from DMD to BMD
3) Use CRISPR to edit the genome

19
Q

What influence neural survival in development?

A

Neurons are overproduced during development
Motor neurons that do not find a muscle fibre to innervate die,
Those that find a muscle to innervate survive.
This is clearly demonstrate by the changes in surviving motor neurons when limbs have been removed or added during embryological development.

20
Q

Describe how innervation of muscle develops from birth onwards?

A

Neurons that have no found a muscle fibre to innervate have already died
However a neuron may have multiple axons innverating a muscle fibre and a muscle fibre may be innervated by many motor neurons.
Synaptic pruning occurs, axons that innervate multiple targets die back -ensures that individual target fibres are innervated by single neurons (one neuron can still innervate multiple muscle fibres)
This process starts rapidly from birth, one axon terminal will outcompete the other and the loser will retract and die.

21
Q

Describe the pattern of synaptic pruning across the brain.

A

Occurs thorughout the brain
Happens faster between age 2 to 10 years.
Number of synapses tends to peak 4 months after birth then gradually increases as we age
Process occurs faster in girls (hence reach maturity faster)
Rate and degree of loss depends on the location in the brain
Key regions in the brain that undergone pruning include the limbic system, the visual system, the motor system and the prefrontal system.

22
Q

Why do we undergo the process of synaptic pruning?

A

Increase the efficiency of synaptic connections - faster and more efficient neurological activity
Often causes solidification of behavioural and thought patterns.

23
Q

Give an overview of what spinal muscular atrophy is.

A

A range of hereditary diseases
Results in death of lower motor neurons typically due to mutated SMN1.
Lack on innervation to muscle results in muscle atrophy

24
Q

What are the four different types of Spinal Muscular Atrophy and how are they different?

A

Types 0-4, higer numbers are less seveere
0 - presents in foetus - die soon after birth as no communication, feeding, motor control and very little pulmonary control
1 - presents at 3 months - no sitting to rolling, requires support feeding, communicating and pulmonary function - survives around 10 months
2 - present at 12 months - sits but no walking, som variable support needed to feeding, communication and plumanory function - live 20yrs
3 - present at 3 years - limited walking, normal feeding and communication, mild pulmonary impairment but no symptoms - normal survival
4 - present older than 18yrs, can walk, feed, communicate and good pulmonary function - normal lifeexpectancy

25
Q

What is the cause of spinal muscular atrophy?

A

SMN1 mutation (autosomal recessive) - leads to decreased expression of SMN1 protein
Survival of Motor neurons 1 is a protein located in the centre of the SMN complex - found mainly in the cytoplasm but also the nucleus
Loss of ability to regulate RNA metabolism, translation and cytoskeleton function
Results in neuron death, particularly alpha motor neurons, results in muscle atrophy from underuse.

26
Q

Why does the genetic evolution of humans make us more vulnerable to Spinal Muscular Atrophy?

A

Undergone human specific gene duplication to produce an SMN1 and an SMN2 gene.
These sequences are almost identical but SMN2 commonly has a mutation that causes splicing problems, splicing out exon 7 90% of the time, meaning only 10% of SMN2 protein is functional.
This means patients with a mutated SMN1 so are reliant on SMN2 are more vulnerable to SMA is they have less copy numbers of SMN2 (as sequence can repeat).

27
Q

How does the number of SMN2 repeats relate to the severity of Spinal Muscular Atrophy disease?

A

1 copy tends to be incompitable with life or type 1 spinal atrophy, with 2 copies being most common in type 1.
Type 2 is predominantly 3 copes with some 2 copies
Type 3 - is mainly3 or 4 copies
Hence more copies of SMN2 means less severe spinal muscular atrophy.

28
Q

What test can be done to indicate spinal muscular atrophy?

A

Neurofilament L (light chain) levels in the blood
Elevated can indicate spinal muscular atrophy - as released from damaged neurons particularly myelinated axons

29
Q

What is the pathogenesis of spinal muscular atrophy?

A

Mutated SMN1 and low copies of SMN2 increase vulnerability
Leads to poor functioning SMN comples leads to poor RNA metabolism, translation and cytoskeleton
Results in neuronal death.
Effect at ventral horn: synaptic dysfunction, loss of synapses, motorneuron hyperexcitability, motorneuron death
Effect on motor neuron: reduced radial growth, impaired schwann cell ensheathment and myelination, degeneration of neuron
Ejject at neurmuscular junction: reduced NMJ maturity, reduced quanta content (vesicle release), denervation
Effect on muscle: reduced myofibre size, impaired development, myofibre loss.

30
Q

What are the treatments for spinal muscular atrophy?**

A

a) exon skipping approach using anti-sense oligonucleotide - nursinersin - nursinersin, inhibits splicing factors to include exon 7 in final transcripy bind to preMRNA
b) risdiplam - small molecule - premRNA splicing modifier to insure the inclusion of exon 7, increase functional protein expressed from SMN2. Binds to preMRNA
c) gene therapy approach to insert functional, SMN gene using an adeno-associated virus taken up by endocytosis, gene in nucleus (not inserted into host genome) expressed alongside host gene, replaces protein functionally.(onasemnogene adaparvovec)

31
Q

What is amyotrophiv lateral sclerosis?

A

A type of motor neuron disease
Loss of motor neurons - die, loss of motor neurons in the ventral horn is clrealy identified on histological images
Complex polygenic disease

32
Q

What are the clincal presentations of a person with amyotrophic lateral sclerosis?

A

Cognitive and behavioural impairement
Dysphagia and dysarthria
respiratory insufficiency
Muscle cramps
Spasticity
Muscle weakness
Muscle atrophy

33
Q

What is thought the be the cause of amytrophic lateral sclerosis?

A

30 genes implicated but is polygenic and with high influence from the environment
No clear inheritance pattern but is thought to be a familial link
Mutated genes tend to be involved in cellular metabolism, such as mitochondrial dysfunction, dysregulated vesciel transport, abnormal RNA metabolism, impaired DNA repait, oxidative stress and impaired homeostasis. Effects muscle most due to higher metabolic rate.
Alternativly some are more specific to neurons - glial dysfunction, hyperexcitability and axonopathy.
Characterised by protein aggregates accumulating in the neuron.

34
Q

How do the symptoms of amyotrophic lateral sclerosis typically progress?

A

Starts as lower motor neurons symptoms
Then develops into upper motor neuron symptoms

Both tend to be affected in typical onset

35
Q

What is thought to cause cerebral palsy?

A

Non-progressive damage to the brain in antenatal, perinatal or early postnatal period.
Includes: preamture birth, hypoxia, infection, head injury, drowning

36
Q

What are the common effects of cerebral palsy on the brain?

A

Hypoplasia - reduced growth
Polymicrogyria - increased number of irregular formed gyri
Subcortical atrophy - loss of basal ganglia or fibres in the subcortical white matter.
And periventricular leukomalacia

37
Q

How does the prevelance of cerebral palsy vary bt the gestational week?

A

The risk of develpoing cerebral palsy is significantly higher at earlier weeks of gestation
However, the majority of children with cerebral palsy are born at normal gestation

38
Q

What muscle pathology is often observed in cerebral palsy?

A

Loss of satellite cells
Decrease in muscle fibre diameter
Increased ECM deposition, particularly laminin.
Decrease growth of muscle, often atrophy,
Highly stretched sarcomeres.
Results in restricted movement and force of contraction

39
Q

What are the clincal manifestation of cerebral palsy?

A

Due to loss of UMN control of motor activity (negative features of UMN syndrome):
- impaired selective motor control
- weakness of muscles
- poor coordination and sensory deficits
Can present as non neural symptoms such as contractures, bony torsion and hip displacement

Due to loss of LMN inhibition (causes positive features of UMNL):
- clonus
- spasticity
- hyperreflexia
-co-contraction
This can present as neural problems like contractures, scoliosis and changes in posture or hip displacement

40
Q

What is meant by diversity in cerebral palsy?

A

Highly heterogeneous disease with a range of causes hence the manifestation of symptoms
Meaning requires a range of interventions

41
Q

What are the different types of disorders in which cerebral palsy may present?*

A

1) Movement disorders - can be from abnormal muscle activation or abnormal reflexes - both of which can cause a dystonic response (involuntary contraction) which can present as a movement disorder to a postural disorder.

2)Stretch reflex disorders - which are due to supraspinal inhibition and present as a spastic response

3) muscle disorder due to trophic changes in the muscle - resulting in muscle fibre-type transformation which causes reduced muscle extensibility and joint range.

42
Q

How do the different types of cerebral palsy disorders present?*

A

Movement and posture disorders (dystonic response) and stretch reflex disorder (spastic response) - show as EMG positive and dynamic muscle resistance. (movement)

Muscle disorders, mainly muscle fibre-type transformation present as EMG negative and passive muscle resistance, can cause contracture and deformity. (note the above can also lead to this)

43
Q

What are the different types of treatment intervention that may be considered in cerebral palsy?

A

Levodopa - treat movement disorders, improves control over movement
Deep brain stimulation - interrupts signals that cause tremors and movement symptoms
Medication to relax skeletal muscles such as - Botox, baclofen or ITB, benzodiazepines, anticholinergics, gabapentin
Selective dorsal rhizotomy to reduce spasticity - irreversibly remove some sensory innervation from the limbs
Orthopaedic surgery - on muscles, tendons, bones and nerves aims to improves anatomical alignment.